Silo pharma enters into sponsored research agreement with columbia university to develop psychedelic therapeutics for alzheimer's disease

Agreement provides for option to license alzheimer's therapeutic agreement provides for option to license alzheimer's therapeutic

SILO Ratings Summary

SILO Quant Ranking